lobbying_activities: 2769251
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2769251 | bb5442cf-6564-45d3-9262-303db27dabf3 | 1T | ADAPTIVE BIOTECHNOLOGIES | 401105856 | ADAPTIVE BIOTECHNOLOGIES | 2022 | first_quarter | HCR | Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022 | HOUSE OF REPRESENTATIVES,SENATE | 240000 | 0 | 1 | 2022-03-23T16:41:33-04:00 |